CP
BMY icon

CenterBook Partners’s Bristol-Myers Squibb BMY Stock Holding History

CenterBook Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.42M Buy
+56,340
New +$3.28M 0.18% 147
2024
Q4 		– Sell
-42,507
Closed -$2.2M – 480
2024
Q3 		$2.2M Buy
+42,507
New +$1.99M 0.14% 186
2023
Q3 		– Sell
-7,605
Closed -$486K – 423
2023
Q2 		$486K Buy
7,605
+782
+11% +$52.4K 0.06% 333
2023
Q1 		$473K Buy
+6,823
New +$481K 0.07% 316

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CenterBook Partners's BMY Position: Q1 2026 in Review

CenterBook Partners opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 56,340 shares worth $3.42M. The stake represents 0.18% of the portfolio and ranks #147 among its holdings. This is a return to the name: CenterBook Partners previously reported a position in BMY as recently as Q3 2024.

CenterBook Partners first reported a position in BMY in Q1 2023 and has held it in 4 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • CenterBook Partners held 56,340 shares of Bristol-Myers Squibb worth $3.42M as of Q1 2026.
  • Bristol-Myers Squibb was a new CenterBook Partners position in Q1 2026.
  • Bristol-Myers Squibb made up 0.18% of CenterBook Partners's portfolio in Q1 2026, its #147 holding.
  • CenterBook Partners first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 4 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on CenterBook Partners's 13F filing for Q1 2026, filed 5 May 2026.